eye drops delay, will prevent, myopia

Published Date: 16 Feb 2023

Researchers have found that dilating eye drops that children use daily can delay the onset of myopia.

Read Full News

Latest News

What Is Causing Progressive Vision Problems in a 32-Year-Old Woman?

A glaucoma diagnosis at a young age should prompt timely genetic testing

Woman Develops Chorioretinal Anastomosis at Site of Photocoagulation Scar

A serendipitous iatrogenic effect following laser surgery in a patient with NF1

Sustained Strategies in Retina: Advancing Long-Acting Therapies for Retinal Vascular Disease

Sustained Strategies in Retina: Advancing Long-Acting Therapies for Retinal Vascular Disease

Real Retinal Decisions: A Clinical Case Challenge in Personalized Retinal Vascular Disease Treatment

Real Retinal Decisions: A Clinical Case Challenge in Personalized Retinal Vascular Disease Treatment

Focus Refined: Applying Emerging Evidence in Pharmacologic Presbyopia Management

Focus Refined: Applying Emerging Evidence in Pharmacologic Presbyopia Management

GLP-1 Drug Linked to Cases of Rare Vision-Altering Condition

Resolution occurred after stopping dulaglutide, no obvious clues to mechanism

Todays Updates

Race, Geography Linked to Gaps in Prostate Cancer Care

A US government study finds racial disparities in care and a complicated relationship between distance to major cancer centers and patients’ treatment and outcomes.

Todays Updates

Race, Geography Linked to Gaps in Prostate Cancer Care

A US government study finds racial disparities in care and a complicated relationship between distance to major cancer centers and patients’ treatment and outcomes.

Latest News

A glaucoma diagnosis at a young age should prompt timely genetic testing

A serendipitous iatrogenic effect following laser surgery in a patient with NF1

Sustained Strategies in Retina: Advancing Long-Acting Therapies for Retinal Vascular Disease

Real Retinal Decisions: A Clinical Case Challenge in Personalized Retinal Vascular Disease Treatment

Focus Refined: Applying Emerging Evidence in Pharmacologic Presbyopia Management

Resolution occurred after stopping dulaglutide, no obvious clues to mechanism

News All Time

Navigating Sustained Delivery in DME: An Interactive Clinical Decision-Making Simulation

Navigating Sustained Delivery in DME: An Interactive Clinical Decision-Making Simulation

Beyond Intravitreal Injections: Advancing Retinal Vascular Disease Care With Sustained Delivery Therapies

Beyond Intravitreal Injections: Advancing Retinal Vascular Disease Care With Sustained Delivery Therapies

Focus Aligned: Patient Selection and Counseling for Pharmacologic Presbyopia Therapies

Focus Aligned: Patient Selection and Counseling for Pharmacologic Presbyopia Therapies

Focus Reengineered: Mechanisms and Clinical Data for Pharmacologic Presbyopia Therapies

Focus Reengineered: Mechanisms and Clinical Data for Pharmacologic Presbyopia Therapies

Mock P&T: Applying the Latest Evidence to Advance Managed Care Decision-Making in Retinal Vascular Disease

Mock P&T: Applying the Latest Evidence to Advance Managed Care Decision-Making in Retinal Vascular Disease

Precision Ocular Care: Integrating Oncology and Eyecare to Conquer Cancer Therapy-Related Toxicities

Precision Ocular Care: Integrating Oncology and Eyecare to Conquer Cancer Therapy-Related Toxicities

ARVO Video Pearls: Video Pearls From The Association for Research in Vision and Ophthalmology

ASRS: American Society of Retina Specialists

AAO: American Academy of Ophthalmology

Trump Showing His Age? Nasal Spray Recalled; Elton John on Losing Sight

Health news and commentary gathered by MedPage Today staff

ARVO: Association for Research in Vision and Ophthalmology

AAO Video Pearls: Video Pearls from the American Academy of Ophthalmology

Pay Cuts and Unnecessary Visits: How Medicare Is Compromising Cataract Care

It's time for payment reform and a lasting remote follow-up option

Higher-Dose Aflibercept Similar to Standard Dose in Severe AMD Variant

Patients with PCV gain standard-dose benefits, with less-frequent dosing

One GLP-1 Drug May Be Better Than Rivals for Glaucoma Risk

But it's not time to prescribe tirzepatide outside current indications, expert says

Color Blindness and Bladder Cancer: A Bad Combination for Survival?

Study suggests inability to identify blood in urine may delay diagnosis and reduce survival

Recommended News For You

In Acute Myeloid Leukemia Diagnosed Recently, FLT3 Inhibitor Is Very Effective.

New imaging technique identifies glioblastoma patients who would benefit from immunotherapy

Study finds that AI is better at forecasting the risk of developing cancer.

Rural residents continue to have higher odds of skin cancer, study finds

Two medications might work better for breast cancers that are resistant to one.

The acceptance of innovative hormonal therapy for advanced prostate cancer is racialized.

Measurable Residual Disease Predicts Real-World AML Relapse

Recommended Articles For You

Understanding Iron Saturation Levels in Your Blood  

Case Study: Diagnostic and Therapeutic Challenges in Aplastic Anemia Mimicking Hypoplastic Myelodysplastic Syndrome 

Citizen-Centered Digital Health Navigation Systems: Advancing Patient Engagement and Optimizing Healthcare Delivery 

Preventing Functional Iron Deficiency in High-Risk Populations 

Whats more on Hidoc Dr.

Medical Updates
KOL Videos
Surveys
Events

Daily news to keep you up to date

Gain valuable insights with our in-depth KOL Video discussions

Participate and win cash vouchers

Get updates on the latest events happening around the world
Featured News
Featured Articles
Featured Events
Featured KOL Videos

1.

Combo of Approved Agents Active in High-Risk Large B-Cell Lymphoma

2.

Elder Abuse: Red Flags to Look Out For While Receiving Care.

3.

Researchers can now forecast how prostate cancer bone metastases will react to radium-223 treatment.

4.

Belantamab Mafodotin: The Comeback Drug in Multiple Myeloma

5.

Scientists pioneer noninvasive 3D imaging to enhance skin cancer management

1.

Essential Applications in Oncology in Daily Practice

2.

Decoding Granular Cell Tumor: What You Need to Know

3.

Unlocking the Power of Hematocrit: Exploring the Benefits of Blood Cell Counts

4.

The Different Types of Cysts and Why They Occur: Insights from a Dermatologist 

5.

Radiation Oncology: Integrating AI, Theranostics, and Adaptive Therapies for Personalized Cancer Care

1.

Asian Symposium on Advancement in Hematology and Oncology

2.

Asian Symposium on Advancement in Hematology and Oncology

3.

Asian Symposium on Advancement in Hematology and Oncology

4.

International Cancer Conference

5.

Asian Symposium on Advancement in Hematology and Oncology

1.

Molecular Contrast: EGFR Axon 19 vs. Exon 21 Mutations - Part V

2.

ESMO Breast Cancer 2022: P Reality X- A Restrospective Analysis

3.

Virtual Case Study on Elephantiasis of Lower Limb- An Initiative by Hidoc Dr.

4.

Untangling The Best Treatment Approaches For ALK Positive Lung Cancer - Part II

5.

The Landscape of First-Line Treatment for Urothelial Carcinoma- The Conclusion

Fastest Growing Medical Platform for Doctors

Address :
Hidoc Dr. Inc. | Delaware C Corp | 1309 Coffeen Ave. Suite 1200, Sheridan WY, 82801

Phone :
+1-415-463-3094

Email :
anishagadia@hidoc.co

Quick Links

Drug DatabaseDrug InteractionDiseases Database
KOL VideosKnowledge HubQuizzes
Medical UpdatesEventsAbout Us

© Copyright 2026 Hidoc Dr. Inc.

Terms & Conditions - LLP | Inc. | Privacy Policy - LLP | Inc. | Account Deactivation
Home
Profile
Login
bot